The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment
Current therapies The current first-line therapies for RRMS are interferon beta or glatiramer acetate (GA). Interferon beta promotes anti-inflammatory cytokines and suppresses CD4+ activation, whereas GA, a synthetic molecule, mimics myelin basic protein,...